Comparative evaluation of cyclacillin and ampicillin in urinary tract infections. A double-blind study.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003514:Cyclohexylamines / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D011513:Proteus mirabilis / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013997:Time Factors; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D003514:Cyclohexylamines; D010406:Penicillins; D000667:Ampicillin; D010397:Penicillanic Acid